Author(s):
Jaya Martolia, Hardik Soni, Falguni Tandel
Email(s):
jmartolia@vasuresearch.com
DOI:
10.5958/0974-360X.2020.00708.8 
Address:
Jaya Martolia1*, Dr. Hardik Soni1, Dr. Falguni Tandel2
1Vasu Research Centre (A Division of Vasu Healthcare Pvt. Ltd.) A2/624-625/2, GIDC, Makakarpura, Vadodara-390010, Gujrat.
2Department of Quality Assurance, Parul Institute of Pharmacy, Parul University, Limda, Waghodiya, Vadodara-391760, Gujarat-India.
*Corresponding Author
Published In:
Volume - 13,
Issue - 8,
Year - 2020
ABSTRACT:
Tuberculosis is a serious health problem in many regions of the world, especially in developing countries. Globally around 2 billion people are suffering from Mycobacterium tuberculosis and every year at approximate 10 million people developed TB disease and 1.3 million deaths. Worldwide approx.160684 cases of MDR/RR-TB were identified. Treatment of TB is a most serious challenge. Major problem of long-term use of existing anti –TB drugs are drug resistance and adverse effects. Drug resistant tuberculosis is widespread and is now a threat to tuberculosis control programme in many countries. Natural products derived from medicinal plants may play a significant role in discovery of new anti-TB drugs. Plants and their secondary metabolites include alkaloids, glycosides, tannins, phenolics, xanthones, quinones, sterols and triterpenoids are reported to have anti-tubercular activity comparable to the existing anti-tubercular drugs. Some of the Phyto molecules and plant extracts were found to be synergistically effective with existing anti TB drugs. Ayurvedic formulations have a significant role in the management of tuberculosis. They act as an adjuvant therapy and bioavailability enhancers. This review demonstrates that Plants, Secondary metabolites and Ayurvedic formulations have potential to cure tuberculosis, drug resistance tuberculosis and minimize adverse effects. They can be used as an alternative treatment for tuberculosis.
Cite this article:
Jaya Martolia, Hardik Soni, Falguni Tandel. Natural perspective for Management of drug resistant Tuberculosis: A Review. Research J. Pharm. and Tech. 2020; 13(8):4002-4008. doi: 10.5958/0974-360X.2020.00708.8
Cite(Electronic):
Jaya Martolia, Hardik Soni, Falguni Tandel. Natural perspective for Management of drug resistant Tuberculosis: A Review. Research J. Pharm. and Tech. 2020; 13(8):4002-4008. doi: 10.5958/0974-360X.2020.00708.8 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2020-13-8-81
REFERENCES:
1. Global tuberculosis report 2018. Available from: URL: http://www.who.int/tb/publications/global_report. 18 September, 2018.
2. World Health Organization 2011, Guidelines for the programmatic management of drug resistant tuberculosis 2011 update.
3. World Health Organization. Available from: URL: http://http://apps.who.int/medicinedocs/en/d/Js2297e. 2002-2005.
4. Pan SY et al., New perspectives on how to discover drugs from herbal medicines: CAM outstanding contribution To modern therapeutics. Evidence Based Complementary and Alternative Medicine. 2013;627375.
5. Huffman MA. Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proceedings of the Nutritional Society. 2003; 62:371-382.
6. Rukachaisirikul T et al., Chabamide, a novel piperine dime from stems of Piper chaba. Planta Medica. 2001; 68:853-855.
7. Suksamrarn Sunit et al., Ziziphine N, O. P and Q, New antiplasmodial cyclopeptide alkaloids from Ziziphus oenoplia var. brunoniana. Tetrahedron. 2005; 61:1175-1180.
8. Rastogi N, Abaul J, Goh KS, Deyallois A, Philogeene E, Bourgeois P. Antimycobacterial activity of chemically defined natural substances from the Caribbean flora in Guadeloupe. FEMS Immunology Medical Microbiology. 1998; 20:267-273.
9. Newton SM et al. The evaluation of forty-Three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. Journal of Ethnopharmacology. 2002; 79:57-67.
10. O’Donnell G et al., Gibbons S. Antibacterial activity of two canthin-6-one alkaloids from Allium neapolitanum. Phototherapy Research. 2007; 21:653-657.
11. Mata R et al., Antimycobacterial compounds from Piper sanctum. Journal of Natural Products.2004; 67:1961-1968.
12. Friis-Moller A et al., In vitro antimycobacterial and antilegionella activity of Licochalcone A from Chinese liquorice roots. Planta Medica. 2002; 68:416–419.
13. Yenjai C et al., Bioactive flavonoids from Kaempferia parviflora. Fitoterapia. 2004; 75:89–92.
14. Gupta V, Fatima A, Faridi U, Negi AS, Shanker K, Kumar JK et al. Antimicrobial potential of Glycyrrhiza glabra roots. J Ethnopharmacol 2008; 116:377–380.
15. Suksamrarn A, Chotipong A, Suavansri T, Boongird S, Timsuksai P, Vimuttipong S et al. Antimycobacterial activity and cytotoxicity of flavonoids from the flowers of Chromolaena odorata. Arch Pharm Res 2004; 27:507–511.
16. Stavri M, Gibbons S. The antimycobacterial constituents of Dill (Anethum graveolens). Phytother Res 2005; 19:938–941.
17. Gu JQ, Wang Y, Franzblau S, Montenegro G, Yang D, Timmermann BN. Antitubercular constituents of Valeriana laxiflora. Planta Medica, 2004; 70:509–514.
18. Agarwal DK et al., Demethoxycurcumin and its semisynthetic analogues as antitubercular agents. Planta Medica. 2008; 74:1828–1831.
19. Newton SM et al., The evaluation of forty-three plant species for in vitro antimycobacterial activities; isolation of active constituents from Psoralea corylifolia and Sanguinaria canadensis. Journal of Ethnopharmacology. 2002; 79:57–67.
20. Snehal S. Patel et al., Systematic review of plant steroids as potential anti-inflammatory agents: current status and future perspectives, The journal of phytopharmacology.2015; 4(2):121-125
21. Saludes JP et al., Antitubercular constituents from the hexane fraction of Morinda citrifolia Linn. (Rubiaceae). Phytotherapy Research. 2002; 16:683- 685.
22. Cantrell CL et al., Antimycobacterial ergosterol5,8-endoperoxide from Ajuga remota. Planta Medica. 1999; 65:732–734.
23. Elsohly HN et al., New antimycobacterial saponin from Colubrina retusa. Journal of Natural Products. 1999; 62:1341–1342.
24. Ignacimuthu S and Shanmugam N 2010 Antimycobacterial activity of two natural alkaloids vasicine acetate and 2-acetyl benzylamine, isolated from Indian shrub Adhatoda vasica Ness. Leaves; J. Biosci. 35 565–570.
25. Ratnakar, P., Murty, P.S. Preliminary studies on the antitubercular activity and the mechanism of action of the water extract of Garlic (Allium sativum) and its two partially purified proteins (Garlic defensins). Indian Journal of Clinical Biochemistry. 11, 1996; A9537–A9541.
26. Prabu A et al., Andrographolide: A Potent Antituberculosis Compound That Targets Aminoglycoside 2’-N-Acetyltransferase in Mycobacterium tuberculosis. Journal of Molecular Graphics and Modelling. 2015;61, 133- 140.
27. Torres-Romero D et al., Dihydro Beta-Agarofuran Sesquiterpenes Isolated from Celastrus vulcanicola as Potential Anti- Mycobacterium tuberculosis Multidrug-Resistant Agents. Bioorganic and Medicinal chemistry Letters.2011;19(7):2182-9.
28. Changtam C et al., Isoxazole analogs of curcuminoids with highly potent multidrug-resistant antimycobacterial activity. European Journal of Medicinal Chemistry. 2010; 45:4446-4457.
29. Andrade-Ochoa S et al., Quantitative structure-activity relationship of molecules constituent of different essential oils with antimycobacterial activity against Mycobacterium tuberculosis and Mycobacterium bovis. BMC Complementary and Alternative Medicine. 2015; 15: 332.
30. Patricia C et al., Antimycobacterial activity of Constituents from Foeniculum vulgare var. Dulce Grown in Mexico. Molecules. 2012; 17: 8471-8482.
31. Chidambaram S et al., In-vitro antimycobacterial activity of selected Indian medicinal plants to resistant strains of Mycobacterium tuberculosis. International Journal of Pharmaceutical Sciences and Research. 2016; 7(10): 4130-33.
32. Birdi T et al., Assessment of the Activity of Selected Indian Medicinal Plants against Mycobacterium tuberculosis: A Preliminary Screening Using the Microplate Alamar Blue Assay. European Journal of Medicinal Plants 2012; 2:308-323.
33. Dey D, Ray R, Hazra B. Antimicrobial Activity of Pomegranate Fruit Constituents against Drug-Resistant Mycobacterium tuberculosis and β-Lactamase Producing Klebsiella pneumoniae. Pharmaceutical Biology. 2015; 53: 1474-1418.
34. Singh R et al., Anti-Mycobacterial Screening of Five Indian Medicinal Plants and Partial Purification of Active Extracts of Cassia sophera and Urtica dioica. Asian Pacific Journal of Tropical Medicine. 2013; 6:366-371.
35. The Ayurvedic Formulary of India Part – I, Second edition,2003, Ministry of Health and Family Welfare, Government of India, Department of Indian System of Medicine and Homeopathy.
36. The Ayurvedic Formulary of India, Part – III, First Edition,2011, Ministry of Health and Family Welfare Government of India, Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy (Ayush).
37. The Ayurvedic Formulary of India, Part – II, First Edition,2000, Ministry of Health and Family Welfare Government of India, Department of Indian System of Medicine and Homoeopathy.
38. Vyas P et al., Clinical evaluation of Rasayana compound as an adjuvant in the management of tuberculosis with anti-Koch’s treatment. Ayu 2012; 33:38-43.
39. Dornala SN, Dornala SS. Clinical efficacy of Bhringarajasava as Naimittika Rasayana in Rajayakshma with special reference to pulmonary tuberculosis. Ayu 2012; 33:523-9.
40. Debnath PK et al., Adjunct therapy of Ayurvedic medicine with anti-tubercular drugs on the therapeutic management of pulmonary tuberculosis. Journal of Ayurveda and Integrative Medicine. 2012; 3:141-9.
41. Sharma YK et al., Hepatoprotective effects of few Ayurvedic herbs in patients receiving antituberculosis treatment. Indian Journal of Traditional Knowledge. 2004;3 :391-6.
42. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. Journal of Antimicrobial Chemotherapy. 2003; 52:1.
43. Mativandlela SPN et al., Antimycobacterial flavonoids from the leaf extract of Galenia africana. Journal of Natural Prodcts. 2009; 72:2169–2171.
44. Bapela NB et al., Activity of 7- methyl juglone in combination with antituberculous drugs against Mycobacterium tuberculosis. Phytomedicine. 2006; 13:630–635.
45. Guo Net al., In vitro activity of isoimperatorin, alone and in combination, against Mycobacterium tuberculosis. Letters in Applied Microbiology. 2014; 58:344-349.
46. Sharma S et al., Protective efficacy of piperine against Mycobacterium tuberculosis. Tuberculosis (Edinburgh). 2014; 94:389-396.
47. Labuschagne A et al., Synergistic antimycobacterial actions of Knowltonia vesicatoria (Lf.) Sims. Evidence Based Complementary Alternative Medicine. 2012;808-979.